Nuclear Medicine/Radioph armaceuticals Market
Nuclear Medicine/Radiopharmaceuticals Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Nuclear Medicine/Radiopharmaceuticals Market Size and Growth
The Nuclear Medicine/Radiopharmaceuticals market is experiencing robust growth, driven by increasing diagnostic applications and advancements in technology. The global market size is projected to reach approximately $12 billion by 2025, with a compound annual growth rate (CAGR) of around 8%. Demand for targeted therapies and improved imaging techniques is fueling this expansion.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ China Isotope & Radiation
◍ Dongcheng
◍ Jaco
◍ Ciaeriar
◍ Advanced Molecular-imaging Solution
◍ Shanghai Atom Kexing
The Nuclear Medicine/Radiopharmaceuticals Market features key players like China Isotope & Radiation and Dongcheng, contributing through innovative products and services. Jaco and Ciaeriar enhance diagnostic capabilities, while Advanced Molecular-imaging Solution and Shanghai Atom Kexing focus on research and development, driving market growth and revenue.
- China Isotope & Radiation: $200 million
- Dongcheng: $150 million
- Jaco: $120 million
- Advanced Molecular-imaging Solution: $100 million
Request Sample Report
Market Segmentation
By Application
Oncology
Thyroid
Cardiology
Request Sample Report
By Product
Diagnostic
Therapeutic
Market Growth
Request Sample Report
$ X Billion USD
